Primeadine
Primeadine

Investing in the age of Longevity: Investment panel

The Longevity Week: Master Investor Masterclass

The Investment Panel investigates demonstrated Longevity growth, name-checking some hot areas for investment, seeing how Longevity-ready institutional investors are and looking forward over the coming year.

On this panel:

Alexandra Sharon Bause, Co-Founder at Apollo Health Ventures, an early-stage investment fund focused on developing interventions that enhance human health and longevity;

Greg Bailey, Co-founder and the CEO of Juvenescence, Greg is a physician, financier and biotech entrepreneur with extensive experience founding and financing healthcare companies;

First Longevity

Dani Saurymper, Healthcare & Longevity Economy Fund Manager, AXA Investment Managers, Danny is expert in Portfolio Management, Equity Research, Equity Sales and Corporate Finance.

The Longevity Week, 9-13 November 2020, is an initiative of The Longevity Forum. It brings together a diverse group of strategic partners of the Forum, supporters and participants whose goals are aligned with the mission of the Forum – to achieve longer, healthier and more fulfilled lives for as many people as possible.

Check-out our weekly blog on Master Investor, and last week’s video, The Science Panel, can be found here.

First Longevity
Phil Newman
Editor-in-Chief Phil is Editor-in-Chief Longevity.Technology and founder of Crowd Longevity a digital investment platform for international investors and Longevity start-ups launching in 2020.

In his career, Phil has held c-level management positions; applying his marketing and business development expertise into these tech sectors: Longevity; IoT; AI; Medical Devices; Biopharma; 3D Manufacturing; Smartgrid and Sustainability.
Primeadine
lumen
Primeadine
lumen

Latest articles

Targeting inflammaging: the hidden “inflammapath” inside us

Keystone Bio seeks funding as it gears up for clinical trials of therapeutic targeting the “keystone pathogen” of chronic inflammaging. Lurking in the mouths of...

Hyperbaric oxygen therapy: a commercial Longevity treatment?

Hyperbaric oxygen therapy can significantly decrease aging characteristics – does it have a future as a commercial Longevity treatment? Aging is made up of many...

Senescence: a new weapon in the fight against cancer

Targeting senescent “zombie” cells may improve cancer survival rates. How well women with cervical cancer respond to treatment (and survive) correlates with the level of...

Wearables and AI on the frontline of Longevity

Disruptive platforms are set for huge growth ahead of the inevitable consolidation and acquisitions: the race is on. Rise and fall used to be the...